ArticlePloS one2026

Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro.

Chelsea Gootjes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.